1.02144

Calcium hydrogen phosphate

anhydrous, fine powder, EMPROVE® ESSENTIAL, Ph. Eur., BP, USP, FCC, E 341(ii)

Manufacturer: SAFC

CAS Number: 7757-93-9

Synonym(S): Calcium hydrogen phosphate, Calcium orthophosphate, Calcium phosphate dibasic

Select a Size

Pack Size SKU Availability Price
1 KG 1.02144-1-KG In Stock ₹ 13,046.29

1.02144 - 1 KG

₹ 13,046.29

In Stock

Quantity

1

Base Price: ₹ 13,046.29

GST (18%): ₹ 2,348.332

Total Price: ₹ 15,394.622

Agency

BPPh. Eur.USP

Quality Level

500

reg. compliance

FCC

product line

EMPROVE® ESSENTIAL

form

fine powder

potency

10000 mg/kg LD50, oral (Rat)>7940 mg/kg LD50, skin (Rabbit)

particle size

(see specification)

pH

7 (20 °C, 10 g/L in H2O, suspension)

mp

370 °C (decomposition)

density

2.89 g/cm3 at 20 °C

Related Products

Img

SAFC

1.02788

powder, EMPROVE® ESSENTIAL, Ph. Eur...

Img

SAFC

1.02143

dried, EMPROVE® ESSENTIAL, Ph. Eur....

Img

SAFC

1.02069

precipitated, EMPROVE® ESSENTIAL, P...

Img

SAFC

1.02064

precipitated (≤ 0.002% Fe), EMPROVE...

Img

SAFC

1.12120

precipitated (≤ 0.0001% Al), EMPROV...

Img

SAFC

1.02787

crystalline, EMPROVE® ESSENTIAL, Ph...

Img

SAFC

1.02102

EMPROVE® ESSENTIAL Ph Eur,BP,USP,E ...

Img

SAFC

1.01750

EMPROVE® ESSENTIAL, Ph. Eur., BP, U...

Description

  • General description: To address challenges of solid formulation manufacturing, we have developed a comprehensive product portfolio to meet with your solid dosage needs in mind. Although solid dose formulations are one of the the most established dosage forms in the pharmaceutical market, the complexity of manufacturing final drug products is becoming more and more challenging. API stability, release kinetics and bioavailability limitations, such as low API solubility, are just a few of many critical obstacles on the way to the market.As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
  • Application: Calcium hydrogen phosphate is a commonly used ingredient in both food and pharmaceutics. In pharmaceutical applications, calcium hydrogen phosphate is primarily used as a filler/binder.
  • Legal Information: Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFETY INFORMATION

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Compare Similar Items

Show Difference

Img

SAFC

1.02144

anhydrous, fine powder, EMPROVE® ES...


Agency:
BPPh. Eur.USP

Quality Level:
500

reg. compliance:
FCC

product line:
EMPROVE® ESSENTIAL

form:
fine powder

potency:
10000 mg/kg LD50, oral (Rat)>7940 mg/kg LD50, skin (Rabbit)

particle size:
(see specification)

pH:
7 (20 °C, 10 g/L in H2O, suspension)

mp:
370 °C (decomposition)

density:
2.89 g/cm3 at 20 °C

Img

SAFC

1.02160

precipitated, EMPROVE® ESSENTIAL, P...


Agency:
BPPh. Eur.

Quality Level:
500

reg. compliance:
__

product line:
EMPROVE® ESSENTIAL

form:
solid

potency:
>10000 mg/kg LD50, oral (Rat)

particle size:
__

pH:
7.0 (20 °C, 50 g/L in H2O, slurry)

mp:
__

density:
2.32 g/cm3 at 20 °C

Img

Supelco

1.02161

precipitated for analysis EMSURE®...


Agency:
__

Quality Level:
300

reg. compliance:
__

product line:
EMSURE®

form:
solid

potency:
>10000 mg/kg LD50, oral (Rat)

particle size:
__

pH:
7.0 (20 °C, 50 g/L in H2O, slurry)

mp:
__

density:
2.32 g/cm3 at 20 °C

Img

Supelco

1.02211

EMPLURA®...


Agency:
__

Quality Level:
200

reg. compliance:
__

product line:
EMPLURA®

form:
liquid

potency:
3188 mg/kg LD50, oral (Rat)

particle size:
__

pH:
__

mp:
__

density:
__